Search Results - Eileen M Boyle
- Showing 1 - 10 results of 10
-
1
-
2
Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size by Celine Berthon, Morgane Nudel, Eileen M. Boyle, Laure Goursaud, Thomas Boyer, Alice Marceau, Bruno Quesnel
Published in Leukemia Research Reports (2020-01-01)Get full text
Article -
3
Challenges in designing and running smouldering myeloma interventional clinical trials by Catherine Lecat, Eileen M Boyle, Daniel Hughes, Lydia Lee, Dean Smith, Ceri Bygrave, Karthik Ramasamy, Kwee Yong
Published in eJHaem (2024-04-01)Get full text
Article -
4
-
5
A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow niche by Hussein Ghamlouch, Dylan C. Gagler, Patrick Blaney, Eileen M. Boyle, Yubao Wang, Jason Avigan, Jinyoung Choi, Ola Landgren, Aristotelis Tsirigos, Francesco Maura, Gareth J. Morgan, Faith E. Davies
Published in Experimental Hematology & Oncology (2025-02-01)Get full text
Article -
6
The Role of Radiotherapy for Patients With Multiple Myeloma in the Modern Era: A Real World Single‐Centre Experience by Dipal Mehta, Maria Gabriel, Nathan Adu‐Poku, Nikolaos Kanellias, Xenofon Papanikolaou, Jonathan Sive, Neil Rabin, Rakesh Popat, Eileen M. Boyle, Lydia Lee, Kwee Yong, Agapi Parcharidou, Suganya Sivabalasingham, Karimali Keshwani, Ke Xu, Charalampia Kyriakou
Published in eJHaem (2025-10-01)Get full text
Article -
7
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma by Cody Ashby, Eileen M. Boyle, Michael A. Bauer, Aneta Mikulasova, Christopher P. Wardell, Louis Williams, Ariel Siegel, Patrick Blaney, Marc Braunstein, David Kaminetsky, Jonathan Keats, Francesco Maura, Ola Landgren, Brian A. Walker, Faith E. Davies, Gareth J. Morgan
Published in Blood Cancer Journal (2022-05-01)Get full text
Article -
8
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma by Aneta Mikulasova, Christopher P. Wardell, Alexander Murison, Eileen M. Boyle, Graham H. Jackson, Jan Smetana, Zuzana Kufova, Ludek Pour, Viera Sandecka, Martina Almasi, Pavla Vsianska, Evzen Gregora, Petr Kuglik, Roman Hajek, Faith E. Davies, Gareth J. Morgan, Brian A. Walker
Published in Haematologica (2017-09-01)Get full text
Article -
9
Current quality of life questionnaires are not relevant for assessing QOL issues in multiple myeloma patients in the era of modern therapies: results from a survey with myeloma pat... by Catherine S. Y. Lecat, Sotirios Bristogiannis, Dipal Mehta, Yadanar Lwin, Joanne Land, Orla McCourt, Orla McCourt, Emma Dowling, Nuno Correia, Neil K. Rabin, Ke Xu, Jonathan Sive, Xenofon Papanikolaou, Rakesh Popat, Lydia Lee, Annabel McMillan, Eileen M. Boyle, Kwee Yong, Charalampia Kyriakou
Published in Frontiers in Oncology (2025-10-01)Get full text
Article -
10
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes by Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, Robert Redd, Eileen M. Boyle, Benny Zhitomirsky, Andrew J. Dunford, Yu-Tzu Tai, Selina J. Chavda, Cody Boehner, Carl Jannes Neuse, Mahshid Rahmat, Ankit Dutta, Tineke Casneuf, Raluca Verona, Efstathis Kastritis, Lorenzo Trippa, Chip Stewart, Brian A. Walker, Faith E. Davies, Meletios-Athanasios Dimopoulos, P. Leif Bergsagel, Kwee Yong, Gareth J. Morgan, François Aguet, Gad Getz, Irene M. Ghobrial
Published in Nature Communications (2022-06-01)Get full text
Article